rs143730975
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_022552.5(DNMT3A):c.89A>G(p.Glu30Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000124 in 1,608,400 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E30A) has been classified as Likely benign.
Frequency
Consequence
NM_022552.5 missense
Scores
Clinical Significance
Conservation
Publications
- Tatton-Brown-Rahman overgrowth syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Heyn-Sproul-Jackson syndromeInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNMT3A | ENST00000321117.10 | c.89A>G | p.Glu30Gly | missense_variant | Exon 3 of 23 | 1 | NM_022552.5 | ENSP00000324375.5 | ||
DNMT3A | ENST00000264709.7 | c.89A>G | p.Glu30Gly | missense_variant | Exon 3 of 23 | 1 | ENSP00000264709.3 | |||
DNMT3A | ENST00000406659.3 | c.89A>G | p.Glu30Gly | missense_variant | Exon 3 of 4 | 1 | ENSP00000384852.3 | |||
DNMT3A | ENST00000380756.7 | n.89A>G | non_coding_transcript_exon_variant | Exon 3 of 24 | 1 | ENSP00000370132.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 6.87e-7 AC: 1AN: 1456254Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 724718 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74320 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: DNMT3A c.89A>G (p.Glu30Gly) results in a non-conservative amino acid change located in the DNA (cytosine-5-)-methyltransferase, N-terminal domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. To our knowledge, no occurrence of c.89A>G in individuals affected with Tatton-Brown Overgrowth Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2868632). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Tatton-Brown-Rahman overgrowth syndrome Uncertain:1
This variant has not been reported in the literature in individuals affected with DNMT3A-related conditions. This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 30 of the DNMT3A protein (p.Glu30Gly). This variant is not present in population databases (gnomAD no frequency). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at